The Born Korea (KRX:475560)

Market Cap	390.10B
Revenue (ttm)	466.92B
Net Income (ttm)	32.45B
Shares Out	14.78M
EPS (ttm)	2,388.88
PE Ratio	11.05
Forward PE	n/a
Dividend	300.00 (1.13%)
Ex-Dividend Date	Apr 2, 2025

Volume	20,005
Average Volume	21,278
Open	27,000
Previous Close	26,650
Day's Range	26,250 - 27,000
52-Week Range	25,300 - 64,500
Beta	n/a
RSI	38.71
Earnings Date	Aug 13, 2025

About Revance Therapeutics

The Born Korea engages in the restaurant business. It operates direct and franchise restaurants in South Korea, the United States, China, Japan, Singapore, Indonesia, Malaysia, the Philippines, and Vietnam. The company was founded in 1993 and is headquartered in Seoul, South Korea.

• Industry: Restaurants
• Sector: Consumer Discretionary
• Founded: 1993
• Country: South Korea
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 475560

Financial Performance

In 2024, The Born Korea's revenue was 464.15 billion, an increase of 13.03% compared to the previous year's 410.66 billion. Earnings were 31.06 billion, an increase of 47.43%.